Trinity Biotech (TRIB) Stock: Buy, Sell, or Hold?
$5.88
+0.54 (+10.08%)
▲
5d:
-10.37%
30d:
-10.37%
90d:
-49.53%
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (77%)
Quality Score
56/100
Position
OVERSOLD
30-Day Fair Range
$6.03 – $7.53
Position: OVERSOLD
Forward P/E & Valuation
-5.4x
Next 12M consensus est.
Wall Street Target
$3.00
-49.0% vs target
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$5.00 / $7.23
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: TRIB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
Get Alerted When TRIB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: TRIB is currently trading at $5.88, which is considered oversold relative to its 30-day fair value range of $6.03 to $7.53.
Technical Outlook: Technically, TRIB is in a strong uptrend. Immediate support is located at $5.00, while resistance sits at $7.23. The stock is showing strong short-term momentum, up 10.1% recently.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $3.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, TRIB is in a strong uptrend. Immediate support is located at $5.00, while resistance sits at $7.23. The stock is showing strong short-term momentum, up 10.1% recently.
Market Sentiment: The stock scores a mixed 42/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. However, the stock is trading significantly above the average Wall Street target of $3.00. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$6.03 -
$7.53
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Trading Range & Key Levels
30-Day Trading Range
$6.03 -
$7.53
Current vs Trading Range
OVERSOLD
Support Level
$5.00
Resistance Level
$7.23
Current Trend
Strong Uptrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (42/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+10.1%)
- BEARISH: Trading 49.0% above Wall St target ($3.00)
- NEUTRAL: Bottoming setup forming (42/100) — watch for confirmation
- CAUTION: 5-day price weakness (-10.4%) - monitor closely
Fundamental Context
Forward P/E (Next Year Est.)
-5.39
Wall Street Target
$3.00
(-49.0%)
Revenue Growth (YoY)
-5.5%
Earnings Growth (YoY)
-77.3%
Profit Margin
-85.4%
Share TRIB Analysis
Share this live TRIB analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 11, 2026 8:24 AM ET
Data refreshes hourly during market hours. Next update: 9:24 AM
Data refreshes hourly during market hours. Next update: 9:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TRIB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
DXCM
DexCom Inc |
STRONG BUY
29 analysts |
$98 | 47 HOLD |
|
EW
Edwards Lifesciences Corp |
STRONG BUY
30 analysts |
$112 | 42 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
28 analysts |
$119 | 37 SELL |
|
SYK
Stryker Corporation |
STRONG BUY
30 analysts |
$340 | 31 SELL |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 49 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive TRIB Research Pages